Abstract
Clinical Impact Of Dose Modification On Response To Ponatinib In Patients With Chronic Phase Chronic Myeloid Leukemia (CP-CML)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1182/blood.v122.21.4007.4007
Journal: Blood | Publication Date: Nov 15, 2013 |
Citations: 6 |
Clinical Impact Of Dose Modification On Response To Ponatinib In Patients With Chronic Phase Chronic Myeloid Leukemia (CP-CML)
Join us for a 30 min session where you can share your feedback and ask us any queries you have